Actualités

Pfizer's CFO joins Nike, Wendy's hires Potbelly Sandwiches' CFO, Airwallex's new CFO boomerangs back to the company and more.

CVS Health’s implied fair value has been updated from US$102.85 to US$105.38 per share, signaling a modest reset in how analysts are framing the stock. Behind this move, recent research highlights stronger engagement potential from GLP 1 programs, improving sentiment toward managed care, and an earnings story that some bullish analysts view as supported by margin recovery and policy visibility, even as more cautious voices flag ongoing risks. Keep reading to see what is driving this evolving...

Florida's Attorney General has opened an investigation into CVS Health's (NYSE:CVS) Caremark pharmacy benefit manager for alleged anticompetitive practices. The probe focuses on claims of steering patients, preferential reimbursement rates, and burdensome audits that may disadvantage independent pharmacies. The investigation centers on Caremark's role in managing prescription drug benefits and its interactions with pharmacies across Florida. CVS Health sits at the intersection of retail...

CI is evolving beyond traditional insurance, using AI, specialty pharmacy and healthcare services to drive growth and sharpen its business focus.

ARS Pharmaceuticals stock collapsed Thursday after CVS Caremark declined to add its epinephrine spray, Neffy, to its formulary.

(Bloomberg) -- Moving from Pfizer Inc. to Nike Inc. may seem like an unusual career shift for a finance chief. For David Denton, it marks a return to the consumer sector after four years in pharmaceuticals.Most Read from BloombergInvestor Who Scored 900% Win in 2008 Crisis Has New Big Short BetGrand Ole Opry House Up For Sale by Owner Ryman HospitalityMicron Shares Soar After AI-Fueled Forecast Shatters ProjectionsStocks Slide as Wall Street Gets AI Wake-Up Call: Markets WrapStocks Erase Gains a

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

While analysts acknowledged incoming finance chief David Denton’s credentials, they also flagged his lack of activewear experience.

David Denton, who has led Pfizer's finances since 2022, will take over as Nike's chief financial officer on Aug. 17

Nike names David Denton, a former Pfizer and CVS Health executive, as its next chief financial officer, and provides updated guidance.

The investigation by Florida’s attorney general comes as states look to check pharmacy benefit managers for allegedly driving up drug costs.

Nike announced a CFO transition and said fourth-quarter results remain on track, excluding a one-time tariff refund benefit.

Florida’s attorney general says he is examining whether CVS’s pharmacy benefit manager steers patients to its own pharmacies.

CVS Health Corporation (NYSE:CVS) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. The New York Times, in an article published on June 11, 2026, pointed to two federal reports from the Department of Health and Human Services and stated that CVS Health Corporation (NYSE:CVS) and other major Medicare Advantage […]

It's expanding its scope of services for GLP-1 obesity medications.

Clover Health Investments, Corp. (NASDAQ:CLOV) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. A caller referenced Cramer’s previous comment, calling it speculative, and noted that the company reported GAAP profitability in Q1 2026 and guided […]

Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find out.

CVS Health is rolling out a first of its kind aluminum bottle for store branded over the counter products across its national pharmacy network. The company is also funding mobile maternal health clinics in underserved rural areas of Missouri, focused on prenatal and mental health services. These moves expand CVS Health’s sustainability and community health efforts beyond its core retail and insurance operations. For investors watching NYSE:CVS, these announcements add context around how the...

Former CEOs of Humana and CVS Health have been appointed as advisors to Optura, an AI focused healthcare startup. UnitedHealth Group (NYSE:UNH) is participating on the advisory side, aligning with efforts to measure and optimize return on AI investment in healthcare. The collaboration brings together major US health insurers and service providers around a shared AI platform approach. For UnitedHealth Group, a large diversified health insurer and services company, this move puts more focus...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at CVS Health (NYSE:CVS) and its peers.

TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.

Dave Denton will leave in August as Pfizer works through its post-COVID reset.

Long before the stock surged, the company had been openly broadcasting its decision to choose profit over scale. The market initially ignored the signal - until the turnaround became undeniable.

Express Scripts and the PBM lobby are following in CVS Caremark’s footsteps in filing complaints challenging the FAIR Rx Act, which was passed earlier this year despite vehement opposition from PBMs.

It's not too late to jump on the bandwagon.

Don't underestimate the potential upside for this diversified healthcare stock.

STNE, USNA, STRA, NEXA and CVS are highlighted as low price-to-book stocks with solid growth projections and strong value scores.

CVS Health Corporation (NYSE:CVS) is included among Billionaire Larry Robbins’ 10 Dividend Stock Picks. On June 4, Morgan Stanley raised its price recommendation on CVS Health Corporation (NYSE:CVS) to $111 from $106. It reiterated an Overweight rating on the shares. The analyst noted that managed care stocks have been “grinding higher” as signs of softer […]

The HHS Office of Inspector General highlights CVS Health's Medicare Advantage arm for high denial rates in post acute care, raising questions about senior access to services. CVS Health advances its primary care partnership with Mass General Brigham after clearing a key regulatory hurdle. Both developments focus attention on NYSE:CVS and its approach to care delivery, costs, and regulatory oversight. These updates arrive while CVS Health, trading at $101.96, has seen the stock up 6.3% over...

With an annual dividend yield of 2.65%, CVS Health Corporation (NYSE:CVS) is included among the 12 High Yield Fortune 500 Stocks to Buy Now. America’s leading health solutions company, CVS Health Corporation (NYSE:CVS), provides advanced health care from pharmacy services and health plans to health and wellness. On June 8, Mizuho upped its price target on […]